Polymorphisms in Toll-Like Receptor Genes and Risk of Cancer

Total Page:16

File Type:pdf, Size:1020Kb

Polymorphisms in Toll-Like Receptor Genes and Risk of Cancer Oncogene (2008) 27, 244–252 & 2008 Nature Publishing Group All rights reserved 0950-9232/08 $30.00 www.nature.com/onc REVIEW Polymorphisms in Toll-like receptor genes and risk of cancer EM El-Omar, MT Ng and GL Hold Department of Medicine and Therapeutics, Institute of Medical Sciences, Aberdeen University, Foresterhill, Aberdeen, UK Host genetic factors are emerging as key determinants of majority of polymorphisms studied are single nucleotide disease risk for many cancers. Identifying candidate genes polymorphisms (SNPs) that occur with a frequency of is a major challenge that has to stem from a profound >1% in the normal population (in contrast to ‘muta- understanding of the pathophysiology of the disease. The tions’ that occur with a frequency of o1%). It is Toll-like receptors are important members of the host’s estimated that up to 10 million SNPs are probably innate immune response and their genes have been found to present in the human genome though not all have thus be polymorphic. This genetic variation allows for a more far been identified. Naturally, most of these SNPs do intricate repertoire that enables the host to withstand not occur in coding sequences, and even those that do, microbial challenges. While this may be advantageous on a are not associated with any alteration in the amino acid population level, there may be less favourable outcomes for sequence and are therefore of no functional conse- individuals that harbour certain genotypes associated with quence. A more useful definition of the variability of excessive immune activation and inflammatory drive. The these SNPs involves haplotype analysis. Haplotypes are damage is often collateral and is manifest in organs where a combination of alleles at different markers along the this chronic inflammation alters normal physiology. A same chromosome that are inherited as a unit. The classic example of this paradigm is the Helicobacter pylori- HapMap project was set up to address this (www. induced gastric cancer model. Another emerging model is hapmap.org) and is a valuable tool that will facilitate prostate cancer where Toll-like receptor polymorphisms the study of genetic polymorphisms relevant to human have also been found to play a role. In this review, we health and disease. Other types of genetic variation discuss polymorphisms in Toll-like receptors and give an include deletion and insertion polymorphisms and insight into how they may influence risk of cancer. microsatellite repeat polymorphisms. Oncogene (2008) 27, 244–252; doi:10.1038/sj.onc.1210912 There has been an exponential rise in the number of published genetic association studies. Quite often, a Keywords: gastric cancer; Helicobacter pylori; genetic report of a single genetic marker is published with great polymorphisms; single nucleotide polymorphisms; promise only to be followed by several negative studies Toll-like receptors; prostate cancer that fail to reproduce the original observation. There is no doubt that the strategy of genetic association studies could be a powerful tool for dissecting human diseases, provided certain principles are observed to minimize the chances of false positive, and negative, reports. The most Introduction important of these principles are (1) rigorous definition of disease phenotype, (2) choice of candidate genes that The completion of the human genome project was a are plausibly linked to the pathophysiology of the disease momentous occasion for humanity. It opened up the under study, (3) selection of polymorphisms with known opportunity to dissect complex human traits and to (or at least potentially) functional consequences, (4) understand basic pathways of health and disease. The choice of genetic markers that are reasonably frequent in strategies for looking at host genetic factors are varied the population under study (variant allele frequency of at and include linkage analysis studies that are suitable for least 5%), (5) appropriate selection of controls that are pursuing rare high-risk alleles in conditions that have a matched for ethnicity, age, gender and environmental hereditary basis. Equally, population-based association exposures, (6) design of studies that are adequately studies are very useful for examining genes with a role in powered to produce a valid result. Even then, the commoner multifactorial diseases that have a strong statistical analyses of such studies have to take into environmental component (Risch, 2000). These associa- account the real problem of false positive results by tion studies often estimate the risk of developing a multiple testing. Appropriate corrections for multiple certain disease in carriers and non-carriers of a testing have to be applied, or alternatively, the positive particular genetic polymorphism. The overwhelming findings should be regarded as preliminary and should be validated in an independent set of cases and controls. Finally, the genetic epidemiology has to involve basic Correspondence: Professor EM El-Omar, Department of Medicine and Therapeutics, Aberdeen University, Institute of Medical Sciences, science in order to unravel and validate the molecular Foresterhill, Aberdeen, Scotland, AB25 2ZD, UK. mechanisms involved. Adherence to these basic princi- E-mail: [email protected] ples will ensure that false positive trails are minimized Toll-like receptor genes and risk of cancer EM El-Omar et al 245 and will offer a true opportunity to understand complex interact with MyD88, which subsequently lowers the multifactorial human diseases. There has never been a production of cytokines especially IL-2 (Kang and more stressing time for adherence to these principles, as Chae, 2001). The polymorphism, which causes an amino the advancement in genotyping technology has made acid change from arginine to tryptophan, has been possible the annotation of the entire human genome. reported to be associated with lepromatous leprosy in a Current technology allows us to genotype up to 500 000 Korean population (Kang and Chae, 2001) and SNPs in one run. We have witnessed a shift towards recurrent bacterial infections in Turkish children these so-called whole genome association studies where (Kutukculer et al., 2007). large multi-centre consortia attempt to examine a very The other well-described TLR2 SNP is also located in the large number of cases and controls for a particular coding region, which is at amino acid position 753 disease. The power of these studies allows for an substituting an arginine residue to a glutamine residue exploratory phase where thousands of SNPs are (Schroder et al., 2003). The polymorphism has been reported examined and a validation phase that attempts to to increase the risk of gram-negative sepsis in a Caucasian replicate positive associations independently. More population (Schroder et al., 2003). Recently, Hamann et al. awesome is the future prospect of replacing genotyping (2005) showed that carriage of the Arg753Gln SNP was also and haplotyping with direct low-cost sequencing of the a risk factor for coronary restenosis, a chronic inflammatory entire genome, the so-called ‘$1000 genome’ (Collins disease, for patients undergoing percutaneous transluminal et al., 2003). coronary angioplasty. In this review, we attempt to shed some light on the In addition to these two SNPs, Jelavic et al. (2006) role of genetic polymorphisms in the Toll-like receptor reported that the allele frequency of a TLR2 guanine- (TLR) genes and how this influences the risk of cancer. thymine (GT) microsatellite repeat polymorphism in the The basic pathobiology of these TLRs in relation to second intron has an impact on the susceptibility to cancer has been discussed extensively in the accompany- sporadic colorectal cancer. Individuals who developed ing reviews and we will concentrate on the role of sporadic colorectal cancer tended to have decreased variations in their genes. We will start by summarizing frequency of alleles 20 and 21 GT repeats and increased some of the published literature on relevant polymorph- frequency of alleles with 31 GT repeats (Jelavic et al., isms in some of the TLRs. We will then discuss specific 2006). Another single polymorphism within TLR2 examples of polymorphisms in TLRs that have been promoter region has been identified to be associated implicated in gastric and prostate cancer. with asthma in children (Yang et al., 2004). The result was supported by a larger study investigating the functionality of TLR2/16934 polymorphism with asth- ma in children of European farmers (Eder et al., 2004). Genetic polymorphisms in Toll-like receptors TLRs play an essential role in innate immunity, being involved in regulation of inflammatory reactions and Toll-like receptor 4 activation of the adaptive immune response to eliminate harmful pathogens. Hundreds of SNPs have been TLR4 is required for innate immunity to gram-negative identified in TLRs but the functional consequences of bacteria. Arbour et al. screened the entire coding region these have not been uncovered in the overwhelming of TLR4 in 82 subjects using single-strand conformation majority. Many associations have been reported be- polymorphism and direct DNA sequencing, and identi- tween TLR polymorphisms and infectious disease or fied a common SNP, an A–G substitution at nucleotide cancers and as we will see later, it is the interaction position þ 896, downstream of the cDNA start codon between infection and chronic inflammation that most (Arbour et al., 2000). This missense mutation leads to an likely mediates the increased risk of cancer
Recommended publications
  • Communicable Diseases Monthly Newsletter
    Communicable Diseases Monthly Newsletter October 2013 Volume 6, Issue 10 What is Pneumonia? neumonia is an infection of the lungs that is Inside This Issue P usually caused by bacteria or viruses. Globally, pneumonia causes more deaths than any 2 Pneumonia other infectious disease. It can often be prevented and can usually be treated. 2 Influenza Update Pneumonia can cause mild to severe illness in 3 people of all ages. Signs of pneumonia can include Communicable Diseases Report coughing, fever, fatigue, nausea, vomiting, rapid breathing or shortness of breath, chills, or chest pain. Certain people that are more likely to become ill with Rabies Awareness pneumonia include adults 65 years of age or older and children younger than 5 4 years. People with underlying medical conditions and those who smoke cigarettes or Sexually Transmitted have asthma are also at increased risk for pneumonia. Diseases Causes of Pneumonia When bacteria, viruses or, rarely, fungi living in your nose, mouth, sinuses, or the (Continued on page 2) Influenza update: 2013-2014 Season s of the week ending November 2, 2013, a total of 7 cases have been A reported in Joplin City (6) and Jasper County (1). Since the beginning of influenza reporting in October, influenza type A represents 85.7 percent of the cases (6 out of 7). This trend shows slightly less reports during the 2013-2014 season when compared with the previous season (2012-2013) within the same period. Influenza virus: Source: CDC.gov (Continued on page 2) Communicable Disease Monthly Newsletter Pneumonia (Continued from page 1) Reduce Your Risk environment spread to your lungs, you can develop Pneumonia can be prevented with vaccines.
    [Show full text]
  • Weekly Epidemiologic L Report
    WEEKLY EPIDEMIOLOGICAL REPORT A publication of the Epidemiology Unit Ministry of Health 231, de Saram Place, Colombo 01000, Sri Lanka Tele: + 94 11 2695112, Fax: +94 11 2696583, E mail: [email protected] Epidemiologist: +94 11 2681548, E mail: [email protected] Web: http://www.epid.gov.lk Vol. 42 No. 33 08 th – 14 th August 2015 Melioidosis Key facts the area. People acquire the disease by inhaling dust contaminated by the bacteria and when the • Melioidosis is an infectious disease caused contaminated soil comes in contact with abraded by a bacterium, Burkholderia pseudomallei. (scraped) area of the skin. Infection most com- • Melioidosis infection commonly involves the monly occurs during the rainy season. lungs. Symptoms • Melioidosis is diagnosed with the help of Melioidosis symptoms most commonly stem blood, urine, sputum, or skin-lesion testing. from lung disease where the infection can form a • Melioidosis is treated with antibiotics. cavity of pus (abscess). The effects can range from mild bronchitis to severe pneumonia. As a • The overall mortality rate is 40%. result, patients also may experience fever, head- Introduction ache, loss of appetite, cough, chest pain, and general muscle soreness. Melioidosis, also called Whitmore's Disease, is an infectious disease caused by a bacterium The effects can also be localized to infection on called Burkholderia pseudomallei (previously the skin (cellulitis) with associated fever and muscle aches. It can spread from the skin known as Pseudomonas pseudomallei-Gram- negative,oxidase positive bacillus). The bacteria are found in contaminated water and soil and spread to humans and animals through direct contact with the contaminated source.
    [Show full text]
  • Reportable Diseases and Conditions
    KINGS COUNTY DEPARTMENT of PUBLIC HEALTH 330 CAMPUS DRIVE, HANFORD, CA 93230 REPORTABLE DISEASES AND CONDITIONS Title 17, California Code of Regulations, §2500, requires that known or suspected cases of any of the diseases or conditions listed below are to be reported to the local health jurisdiction within the specified time frame: REPORT IMMEDIATELY BY PHONE During Business Hours: (559) 852-2579 After Hours: (559) 852-2720 for Immediate Reportable Disease and Conditions Anthrax Escherichia coli: Shiga Toxin producing (STEC), Rabies (Specify Human or Animal) Botulism (Specify Infant, Foodborne, Wound, Other) including E. coli O157:H7 Scrombroid Fish Poisoning Brucellosis, Human Flavivirus Infection of Undetermined Species Shiga Toxin (Detected in Feces) Cholera Foodborne Disease (2 or More Cases) Smallpox (Variola) Ciguatera Fish Poisoning Hemolytic Uremic Syndrome Tularemia, human Dengue Virus Infection Influenza, Novel Strains, Human Viral Hemorrhagic Fever (Crimean-Congo, Ebola, Diphtheria Measles (Rubeola) Lassa, and Marburg Viruses) Domonic Acid Poisoning (Amnesic Shellfish Meningococcal Infections Yellow Fever Poisoning) Novel Virus Infection with Pandemic Potential Zika Virus Infection Paralytic Shellfish Poisoning Plague (Specify Human or Animal) Immediately report the occurrence of any unusual disease OR outbreaks of any disease. REPORT BY PHONE, FAX, MAIL WITHIN ONE (1) WORKING DAY Phone: (559) 852-2579 Fax: (559) 589-0482 Mail: 330 Campus Drive, Hanford 93230 Conditions may also be reported electronically via the California
    [Show full text]
  • 48787.Pdf (462.8Kb)
    V directing council regional committee PAN AMERICAN WORLD t°3' ) HEALTH HEALTH ORGANIZATION ORGANIZATION - XV Meeting XVI Meeting Mexico, D.F. August-September 1964 Provisional Agenda Item 33 CD15/30 (Eng.) 15 July 1964 ORIGINAL: ENGLISH REVIEW OF THE STATUS OF THE VENEREAL DISEASE PROBLEM AND CONTROL PROGRAMS IN THE AMERICAS I. IMPORTANCE OF THE PROBLEM * The venereal diseases are truly word-wide in occurrence -- but the exact extent of the problem is unknown. Variations in morbidity reporting practices from country to country and, indeed, within countries, make it difficult to compile reliable statistics relating to the incidence and prevalence of the venereal diseases. In the United States, where a vigorous venereal disease control program has been carried on since 1940, the figures from a recent survey of case reporting by private physicians indicate that only 11 per cent of the cases of infectious syphilis, 38 per cent of the cases of other stages of syphilis, and 11 per cent of the cases of gonorrhea treated by private physicians during the survey period were reported to the health department. In spite of the under-reporting problem, Guthe and Hume estimated in 1948 that at least two million cases of new venereally acquired. syphilis occurred in the world annually. In terms of prevalence, they estimated that a total of 20 million cases of syphilis existed among persons over 15 years of age throughout the world. There has been a tremendous increase in the world's population since 1948. There have been similar increases in factors affecting the rate of spread of syphilis such as greatly increased mobility and migration, as well as an apparent increase in sexual promiscuity.
    [Show full text]
  • Bacterial Infections
    The Lower Respiratory Tract Common Clinical Conditions Bacterial diseases of the LRT are outlined below. Other Bacterial Diseases Bacterial Infections Common Clinical Conditions Pertussis (whooping cough): Caused by Bordetella Bacterial Pneumonias pertussis, this highly contagious childhood disease pro- Pneumococcal pneumonia: Streptococcus pneumo- duces mucus in the respiratory system, which triggers niae is responsible for about 80% of all pneumonia coughing. Straining for air causes the “whooping” cases. It usually starts after an URT viral infection dam- sound. [FOM pp. 279–280] ages the airways. Without appropriate antibiotic treat- Tuberculosis: An infection by Mycobacterium tuber- ment, mortality is high, especially in the elderly. [FOM he lower respiratory tract (LRT) consists of the (Streptococcus, Mycoplasma, Chlamydia), producing culosis, the major causative agent of tuberculosis (TB), pp. 289–290] Tlarynx (voice box), trachea (windpipe), bronchial a thick mucus that narrows the airways. starts by inhaling bacilli from an infected person. In the Primary atypical (walking) pneumonia: Caused by tubes, and the alveoli. Due to the mucous membrane Bronchiolitis: Usually restricted to young chil- alveoli, the bacilli reproduce, leading to calcified aggre- and filtering mechanisms of the bronchial tubes, the Mycoplasma pneumoniae, the infection is common in gations of activated macrophages and lymphocytes dren, a viral infection of the bronchiole lining children and teenagers. The disease is rarely fatal. LRT normally contains few microbes. Therefore, if (tubercles) surrounding the bacteria. [FOM pp. causes a swelling and narrowing of the airways, [FOM pp. 290–292] 284–288] pathogens enter the LRT, serious respiratory disease making expiration difficult (a wheezing sound Legionellosis (Legionnaires’ disease): Legionella may result.
    [Show full text]
  • Poorhouse Record of Diseases 1840-1842
    Poorhouse Record of Diseases 1840-1842 Last Name First Name Age Disease Year Page 2Worms 1841 8 2Worms 1842 13 Augustus4 Measles 1841 2 Dummy6 Worms/Convulsions 1841 4 George15 Marasmus 1842 10 George2 Cattarrh 1842 9 HarryFrozen feet/Mortification 1842 13 Henry3Whooping cough 1842 10 Jeremiah80 Phthisis Pulmonalis 1842 10 John5 Measles 1841 2 Sammy2 Cattarrh 1842 9 Viney3 Convulsions 1841 3 Barr James66 Pneumonia 1841 1 Barr James66 Haemopthisis 1841 3 Barrett Hiram38 Remittent fever 1842 11 Barrett Joshua48 Cholera Morbus 1841 3 Bates Lydia 1826 5 Batt Michael81 Debility 1841 3 Benderman Sam30 Acute Hepatitis 1842 12 Bennerman Thomas3Scalded head 1841 1 Birkit John25 Typhus fever 1842 11 Birkit John25 Fever 1842 12 Bishop Perry25 Inf. of lungs/Insane 1841 3 Bond Jesse45 Phthisis Pulmonalis 1841 4 Bond Mary Ann4 Measles 1841 2 Boocher Lucetta23 Diarrhea/pertonitis 1842 11 Bowers Mary25 Amenorrhea 1841 4 Bowers Mary25 Spinal disease/Anasarca 1842 10 Bowers William4 days Convulsions 1841 1 Boyers Ann 5 Boyers Ann Insane 1842 8 Chester County Archives and Record Services, West Chester, PA 19380 Last Name First Name Age Disease Year Page Braden Jane 79 Prolapsis Ani 1 Brenderman Edith2 Diarrhea 1842 11 Brenderman Edith2Worms 1842 8 Brenderman Edith17 months Whooping cough 1842 9 Brenderman Jane34 Catarrh 1842 8 Brenderman Thomas4Whooping cough 1842 9 Brenneman 1Dysentery 1841 2 Brenneman Edith8 months Measles 1841 2 Brenneman JaneCholera Morbus 1841 2 Brenneman JaneHamatemesis 1842 8 Brenneman Thomas4 Measles 1841 2 Brown 2Cholera Infantum
    [Show full text]
  • What Is Pertussis (Whooping Cough)?
    American Thoracic Society PATIENT EDUCATION | INFORMATION SERIES What Is Pertussis (Whooping Cough)? Pertussis is a very contagious respiratory infection commonly known as ‘whooping cough’. It is caused by a bacterium called Bordetella pertussis. The infection became much less common after a successful vaccine was developed and given to children to help prevent infection. However, in recent years, the number of people infected with pertussis has increased and now is at the highest rate seen since the 1950’s. There is concern that this is due mainly to people not taking the pertussis (whooping cough) vaccination and adults who have not had a booster and their immune protection has weakened with age. Whooping cough usually starts as a mild cold-like illness get in the air. If you are close enough, you can breathe in these (upper respiratory infection). The pertussis bacteria enter the droplets or they can land on your mouth, nose, or eye. You lungs and cause swelling and irritation in the airways leading can also get the infection if you kiss the face of a person with to severe coughing fits. At times, people with whooping pertussis or get infected nose or mouth secretions on your cough can have a secondary pneumonia from other bacteria hands and then touch your own face to rub your eyes or nose. while they are ill. Whooping cough can cause very serious A person with pertussis can remain contagious for many weeks illness. It is most dangerous in young babies and can result unless treated with an antibiotic. in death. It spreads very easily and people who have the infection can still spread it to others for weeks after they What are the symptoms of Pertussis infection? become sick.
    [Show full text]
  • Pertussis, Or Whooping Cough, Is an Acute Infectious Disease Caused by the Bacterium Bordetella Pertussis
    Pertussis Pertussis, or whooping cough, is an acute infectious disease caused by the bacterium Bordetella pertussis. Outbreaks of pertussis were first described in the 16th century, and the organism was first isolated in 1906. In the 20th century pertussis was one of the most common childhood diseases and a major cause of childhood mortality in the United States. Prior to the availability of pertussis vaccine in the 1940s, more than 200,000 cases of pertussis were reported annually. Since widespread use of the vaccine began, incidence has decreased more than 98%, to an average of about 4,400 cases per year since 1980. 7 Pertussis remains a major health problem among children in developing countries, with an estimated 285,000 deaths resulting from the disease in 2001. BORDETELLA PERTUSSIS B. pertussis is a small aerobic gram-negative rod. It is fastidious, and requires special media for isolation (see section on Laboratory Diagnosis). B. pertussis produces multiple antigenic and biologically active products, including pertussis toxin, filamentous hemagglutinin, agglutinogens, adenylate cyclase, pertactin, and tracheal cytotoxin. These products are responsible for the clinical features of pertussis disease, and an immune response to one or more produces immunity to subsequent clinical illness. Recent evidence suggests that immunity from B. pertussis infection may not be permanent. PATHOGENESIS Pertussis is primarily a toxin-mediated disease. The bacteria attach to the respiratory cilia, produce toxins that paralyze the cilia, and cause inflammation of the respiratory tract, which interferes with the clearing of pulmonary secretions. Pertussis antigens appear to allow the organism to evade host defenses, in that lymphocytosis is promoted, but chemotaxis is impaired.
    [Show full text]
  • Healthy Brookline Volume
    HEALTHY BROOKLINE VOLUME XVI Communicable Diseases in Brookline Brookline Department of Public Health 2015 ACKNOWLEDGEMENTS This report was prepared by Janelle Mellor, MPH, with support from Natalie Miller, MPH, Barbara Westley, RN, and Lynne Karsten, MPH, under the direction of Alan Balsam, PhD, MPH, Director of Public Health and Human Services in Brookline. Thanks are also due to the Division Directors at the Brookline Department of Public Health for their support and input: Lynne Karsten, MPH Patrick Maloney, MPAH Mary Minott, LICSW Patricia Norling Gloria Rudisch, MD, MPH Dawn Sibor, MEd Barbara Westley, RN A special thanks to the Brookline Advisory Council on Public Health Bruce Cohen, PhD-Chair Roberta Gianfortoni, MA Milly Krakow, PhD Cheryl Lefman, MA Patricia Maher, RN/NP, MA/MA Anthony Schlaff, MD, MPH Support and data were also provided by: Susan Soliva, MPH, Massachusetts Department of Public Health The Healthy Brookline Chartbooks represent a partnership with a variety of funding sources: Beth Israel Deaconess Medical Center Brigham & Women’s Hospital Children’s Hospital Farnsworth Trust Tufts Medical Center St. Elizabeth’s Medical Center Blue Cross Blue Shield of Massachusetts Brookline Community Foundation Harvard Pilgrim Health Care Foundation Tufts Health Plan We thank them all for their generous support. Table of Contents Section 1: Communicable Disease Surveillance and Reporting .................................................................. 1 Surveillance and Reporting ......................................................................................................................
    [Show full text]
  • ICD-10 Coordination and Maintenance Committee Meeting March 17-18, 2020 Diagnosis Agenda Webex Instructions for Remote Meeting Participation
    ICD-10 Coordination and Maintenance Committee Meeting March 17-18, 2020 Diagnosis Agenda WebEx Instructions for Remote Meeting Participation Remote participants (attendees wishing to both view slides and ask questions during the Q&A portions of the meeting) must join the meeting by WebEx*. • Day 1: March 17, 2020: The meeting will begin promptly at 9:00 AM ET and will end at 5:00 PM ET. Lunch will be held from 12:30 PM to 1:15 PM. 1. Event address for attendees: https://letsmeet.webex.com/letsmeet/onstage/g.php?MTID=e20f2a065e507d5e156f34aa9076e32e8 2. Event password: This event does not require a password for attendees. If you have any questions regarding the presentations, please use the raise hand feature during the Q&A session after each presentation and your line will be unmuted. Once your question has been addressed, please lower the raised hand. • Day 2: March 18, 2020: The meeting will begin promptly at 9:00 AM ET and will end at 5:00 PM ET. Lunch will be held from 12:30 PM to 1:15 PM. 1. Event address for attendees: https://letsmeet.webex.com/letsmeet/onstage/g.php?MTID=e0e9e3e18a86ed9277fac903a52d8880a Event password: This event does not require a password for attendees. If you have any questions regarding the presentations, please use the raise hand feature during the Q&A session after each presentation and your line will be unmuted. Once your question has been addressed, please lower the raised hand. ICD -10 Coordination and Maintenance Committee Meeting March 17-18, 2020 *Detailed instructions for joining the WebEx meeting are posted in the "Downloads" section located here: https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials If you experience technical difficulties during the meeting, please contact Michele Hudson for assistance at [email protected] or 443-821-4266.
    [Show full text]
  • Infectious Diseases in South Dakota 2008
    INFECTIOUS DISEASES IN SOUTH DAKOTA 2008 The South Dakota Department of Health (DOH) is authorized by South Dakota Codified Law 34-22-12 and Administrative Rules Article 44:20 to receive and process mandatory reports of communicable diseases by physicians, hospitals, laboratories, and institutions. Category I: Report immediately on Category II: Report within 3 days suspicion of disease Anthrax (Bacillus anthracis) Acquired immunodeficiency syndrome (AIDS) Influenza: 1) hospitalizations and deaths; 2) lab confirmed Botulism (Clostridium botulinum) Arboviral encephalitis, meningitis and infection cases (culture, DFA, PCR); 3) weekly aggregate report of Cholera (Vibrio cholerae) (West Nile, St. Louis, Eastern and Western equine, total rapid antigen positive test (A & B) and total tested Diphtheria (Corynebacterium diphtheriae) California serotype, Japanese, Powassan) Legionellosis (Legionella spp.) Enterohemorrhagic E. coli (EHEC) shiga toxin- Brucellosis (Brucella spp.) Leprosy/Hansen’s disease (Mycobacterium leprae) producing (Escherichia coli), includes E. coli O157:H7 Campylobacteriosis (Campylobacter spp.) Listeriosis (Listeria monocytogenes) Measles (paramyxovirus) Chancroid (Haemophilus ducreyi) Lyme disease (Borrelia burgdorferi) Meningococcal disease, invasive (Neisseria meningitidis) Chicken pox/Varicella (herpesvirus) Malaria (Plasmodium spp.) Plague (Yersinia pestis) Chlamydia infections (Chlamydia trachomatis) Melioidosis (Burkholderia pseudomallei) Poliomyelitis (picornavirus) Cryptosporidiosis (Cryptosporidium parvum) Mumps
    [Show full text]
  • The Epidemiology of Infectious Diseases in Illinois, 1999 TABLE of CONTENTS
    The Epidemiology of Infectious Diseases in Illinois, 1999 TABLE OF CONTENTS Reportable communicable diseases in Illinois..................................1 1999 summary of selected Illinois infectious diseases ...........................2 Acquired immune deficiency syndrome/Human immunodeficiency virus ............4 Amebiasis..............................................................9 Animal bites...........................................................11 Blastomycosis .........................................................13 Brucellosis............................................................15 Campylobacteriosis .....................................................16 Central nervous system infections ..........................................19 Aseptic meningitis .................................................19 Encephalitis .......................................................22 Bacterial meningitis ................................................27 Haemophilus influenzae (invasive disease) ..............................28 Listeriosis ........................................................30 Invasive Neisseria meningitidis .......................................31 Streptococcus pneumoniae meningitis ..................................35 Streptococcus, invasive group B .......................................38 Cryptosporidiosis.......................................................41 Ehrlichiosis ...........................................................44 E. coli O157:H7 ........................................................46
    [Show full text]